Aether Industries Ltd Q1 FY27 Results Analysis: Revenue Surges 27%, EBITDA Margin Rebounds

CompoundingAI Research Updated July 31, 2026 2 min read
Positive

Aether Industries Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 326.56 Cr (+27.25% YoY) and PAT growth of +33.45% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 31, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 326.56 Cr (+27.25% YoY)
PAT (Q1)Rs. 62.75 Cr (+33.45% YoY)
EBITDA margin31.47%
EPS (Q1)Rs. 4.77 (+34.37% YoY)
Market capRs. 20,453.77 Cr
CMPRs. 1,539.60

Quarter Snapshot

Revenue grew 27.25% YoY, exceeding the ~25% guidance, with EBITDA margin rebounding to 31.47% as logistical issues resolved. Employee cost and depreciation rose sharply, while a one-time insurance gain inflated reported PAT. The credit outlook revision to Stable is a partial offset.

Key Investment Insights

Key Positives

  • Revenue grew 27.25% YoY to Rs.326.56 Cr, above the ~25% guidance run-rate.
  • EBITDA margin improved to 31.47% (reported) from 26.66% in Q4FY26, a 481 bps QoQ expansion.
  • PAT grew 33.45% YoY to Rs.62.75 Cr.
  • Cost of materials ratio improved to 50.17% (COGS/revenue) from 56.34% in Q4FY26.
  • No exceptional items this quarter, compared to Rs.13.25 Mn in Q4FY26.
  • Normalized EBITDA margin of 30.40% (ex-FLOP gain) within management's 29-30% sustainable range.

Risk Factors

  • Employee costs grew 39.97% YoY, outpacing revenue growth of 27.25% YoY.
  • Depreciation rose 50.81% YoY to Rs.21.42 Cr, pressuring PBT due to capacity additions.
  • Reported PAT includes a Rs.35 Mn one-time insurance gain; normalized PAT is Rs.60.12 Cr, 4.2% lower than reported.
  • ICRA revised credit rating outlook from Positive to Stable in May 2026, indicating a cautious view.
  • Working capital days remained high at ~179 days in Q4FY26, and the Q1FY27 balance sheet is not disclosed.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now